Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Actuarial Approach01:20

Actuarial Approach

140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

281
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
281
Prevalence and Incidence01:08

Prevalence and Incidence

841
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
841
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

303
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
303
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Characteristics, Incidence, And Survival Of Unknown Stage Cancer: A Us Population-based Study.
  1. Home
  2. Characteristics, Incidence, And Survival Of Unknown Stage Cancer: A Us Population-based Study.

Related Experiment Video

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201

Characteristics, incidence, and survival of unknown stage cancer: A US population-based study.

Ray M Merrill1, Alida J Johnson1

  • 1Brigham Young University, Department of Public Health, College of Life Sciences, Provo, UT 84602, USA.

Cancer Treatment and Research Communications
|June 3, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Males, older individuals, Black, and Hispanic populations face higher rates of unstaged cancer, impacting survival. This highlights disparities in cancer staging and care.

Keywords:
CancerIncidencePopulation-basedRelative survivalSEERUnknown stage

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

381
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Oncology
  • Cancer Epidemiology
  • Public Health

Background:

  • Cancer staging is crucial for treatment and prognosis.
  • Understanding the incidence of unstaged cancer is vital for identifying healthcare disparities.

Purpose of the Study:

  • To examine the extent and patterns of unknown stage cancer incidence across 24 cancer sites in the U.S.
  • To identify demographic and reporting source factors associated with unstaged cancer.

Main Methods:

  • Analysis of 5,447,023 malignant cancer cases from 2015-2021.
  • Utilized data from 22 population-based cancer registries in the Surveillance, Epidemiology, and End Results (SEER) Program.
  • Employed Poisson regression to estimate adjusted rate ratios.

Main Results:

  • Approximately 9.4% of males and 7.2% of females were diagnosed with unstaged cancer.
  • Unstaged cancer rates varied significantly by reporting source, with autopsy and death certificates showing the highest percentages.
  • Males, older individuals, Black, and Hispanic populations, and those with lower income exhibited higher rates of unstaged cancer. A negative association was observed between unstaged cancer and 5-year relative survival rates.

Conclusions:

  • Males, older age, Black, and Hispanic patients are more susceptible to unstaged cancer.
  • Factors contributing to unstaged cancer include higher comorbidity, more aggressive cancer, and financial barriers to treatment.
  • Addressing these disparities is essential for improving cancer outcomes across diverse populations.